Assessment of presence and grade of activity in ileal Crohn's disease

Turkish Journal of Gastroenterology

Volumn 25, Issue 3, 2014, Pages 264-270

  Yüksel, Elif Saritaş ^a   Ipek, Serkan ^a   Topal, Firdevs ^a   Koç, Gonca ^a   Akpinar, Zehra ^a   Slaughter, James C ^b   Oyar, Orhan ^a   Ünsal, Belkis ^a  

^a Izmir Ataturk Teaching Hospital   (Turkey)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Activation; Crohn's disease; Ileocolonoscopy; Magnetic resonance enterography

Indexed keywords

C REACTIVE PROTEIN; GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTRAST ENHANCEMENT; CORRELATIONAL STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; FEMALE; HEMICOLECTOMY; HUMAN; LEUKOCYTE COUNT; MAGNETIC RESONANCE ENTEROGRAPHY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; THROMBOCYTE COUNT; YOUNG ADULT; COMPARATIVE STUDY; DISEASE COURSE; GASTROINTESTINAL ENDOSCOPY; ILEITIS; SEVERITY OF ILLNESS INDEX;

ADULT; CROHN DISEASE; DISEASE PROGRESSION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; ILEITIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84908143834     PISSN: 13004948     EISSN: 21485607     Source Type: Journal    
DOI: 10.5152/tjg.2014.3862     Document Type: Article

References (38)

1. Hafeez R, Punwani S, Boulos P, et al. Diagnostic and therapeutic impact of MR enterography in Crohn's disease. Clin Radiol 2011; 66: 1148-58. [CrossRef]
2. Pera A, Bellando P, Caldera D, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987; 92: 181-5.
3. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989; 30: 983-9. [CrossRef]
4. Landi B, Anh TN, Cortot A, et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology 1992; 102: 1647-53.
5. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004; 60: 505-12. [CrossRef]
6. Rutgeerts P. A critical assessment of new therapies in inflammatory bowel disease. J Gastroenterol Hepatol 2002; 17 (Suppl): S176-85. [CrossRef]
7. D'Haens G, Daperno M. Advances in medical therapy for Crohn's disease. Curr Gastroenterol Rep 2002; 4: 506-12. [CrossRef]
8. Sipponen T, Savilahti E, Karkkainen P, et al. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNFalpha therapy for Crohn's disease. Inflamm Bowel Dis 2008; 14: 1392-8. [CrossRef]
9. Martinez MJ, Ripolles T, Paredes JM, Blanc E, Marti-Bonmati L. Assessment of the extension and the inflammatory activity in Crohn's disease: Comparison of ultrasound and MRI. Abdom Imaging 2009; 34: 141-8. [CrossRef]
10. O'Donovan AN, Somers S, Farrow R, Mernagh JR, Sridhar S. MR imaging of anorectal Crohn disease: a pictorial essay. Radiographics 1997; 17: 101-7. [CrossRef]
11. Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000; 25: 219-28. [CrossRef]
12. Debatin JF, Patak MA. MRI of the small and large bowel. Eur Radiol 1999; 9: 1523-34. [CrossRef]
13. Feuerbach S. MRI enterography: The future of small bowel diagnostics? Dig Dis 2010; 28: 433-8.
14. Girometti R, Zuiani C, Toso F, Brondani G, Sorrentino D, Avellini C, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. Acad Radiol 2008; 15: 153-64. [CrossRef]
15. Sempere GA, Martinez Sanjuan V, Medina Chulia E, et al. MRI evaluation of inflammatory activity in Crohn's disease. AJR Am J Roentgenol 2005; 184: 1829-35. [CrossRef]
16. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001; 177: 1325-32. [CrossRef]
17. Laghi A, Paolantonio P, Iafrate F, et al. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease. Radiol Med 2003; 106: 18-27.
18. Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn's disease: Monitoring disease activity. Aliment Pharmacol Ther 2003; 17 (Suppl 2): S11-7. [CrossRef]
19. Rodgers AD, Cummins AG. CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease. Dig Dis Sci 2007; 52: 2063-8. [CrossRef]
20. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956-63.
21. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 665-72. [CrossRef]
22. Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010; 138: 463-8. [CrossRef]
23. Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006; 63: 433-42. [CrossRef]
24. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-95. [CrossRef]
25. Flynn A, Kane S. Mucosal healing in Crohn's disease and ulcerative colitis: What does it tell us? Curr Opin Gastroenterol 2011; 27: 342-5. [CrossRef]
26. Jensen MD, Nathan T, Rafaelsen SR, Kjeldsen J. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 2011; 9: 124-9. [CrossRef]
27. Knuesel PR, Kubik RA, Crook DW, Eigenmann F, Froehlich JM. Assessment of dynamic contrast enhancement of the small bowel in active Crohn's disease using 3D MR enterography. Eur J Radiol 2010; 73: 607-13. [CrossRef]
28. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: Preliminary results. Eur Radiol 2004; 14: 1017-24. [CrossRef]
29. Feldstein RC, Sood S, Katz S. Small bowel adenocarcinoma in Crohn's disease. Inflamm Bowel Dis 2008; 14: 1154-7. [CrossRef]
30. Gallego JC, Echarri AI, Porta A, Ollero V. Ileal Crohn's disease: MRI with endoscopic correlation. Eur J Radiol 2011; 80: e8-12. [CrossRef]
31. Horsthuis K, Bipat S, Stokkers PC, Stoker J. Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review. Eur Radiol 2009; 19: 1450-60. [CrossRef]
32. Schreyer AG, Golder S, Scheibl K, et al. Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn's disease: First clinical experience. Inflamm Bowel Dis 2005; 11: 388-94. [CrossRef]
33. Schreyer AG, Rath HC, Kikinis R, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut 2005; 54: 250-6. [CrossRef]
34. Shoenut JP, Semelka RC, Magro CM, Silverman R, Yaffe CS, Micflikier AB. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994; 19: 31-5. [CrossRef]
35. Durno CA, Sherman P, Williams T, Shuckett B, Dupuis A, Griffiths AM. Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2000; 30: 170-4. [CrossRef]
36. Laghi A, Borrelli O, Paolantonio P, et al. Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease. Gut 2003; 52: 393-7. [CrossRef]
37. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005; 3: 1221-8. [CrossRef]
38. van Gemert-Horsthuis K, Florie J, Hommes DW, Lavini C, Reitsma JB, van Deventer SJ, et al. Feasibility of evaluating Crohn's disease activity at 3.0 Tesla. J Magn Reson Imaging 2006; 24: 340-8. [CrossRef]